irritable bowel syndrome
EnteroBiotix begins phase 2 trial of IBS treatment
April 3, 2024Research and Development EnteroBiotix, Gastrointestinal tract, IBS, irritable bowel syndrome
EnteroBiotix has announced that it has dosed the first patient in its multi-centre, randomised, double-blind, placebo controlled clinical trial, which …
Immune system exhaustion associated with irritable bowel syndrome
June 21, 2017Research and Development IBS, irritable bowel syndrome, t cells
Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …
IBS-D treatment Truberzi receives positive opinion from CHMP
July 26, 2016Manufacturing and Production, Sales and Marketing Allergan, EU, Truberzi, diarrhoea. CHMP, irritable bowel syndrome
Global pharmaceutical company Allergan has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of …
Takeda and Enterome collaborate on new therapeutics for stomach disorders
January 6, 2016Research and Development Enterome, Takeda, gastrointestinal, inflammatory bowel syndrome, irritable bowel syndrome
Takeda and Enterome Bioscience have entered a drug discovery collaboration to research and develop potential new therapeutics for disorders including …
